甲状腺手术局部止血剂网状Meta分析
结果显示活性或被动止血剂均未降低再手术血肿率,活性止血剂可减少总失血量和手术时间。
要点
- 局部止血剂未降低甲状腺术后需再手术的颈部血肿率
- 活性止血剂可显著减少术后总失血量和缩短手术时间
- 引流管拔除时间、住院时长及低钙血症或喉返神经麻痹率无差异
核心结论
- 局部止血剂的普遍使用未被证明能降低临床相关出血率。
研究设计与样本
- 采用贝叶斯随机效应模型进行网状Meta分析,先验分布为最小信息先验。
主要发现
- 引流管拔除时间、住院时长、术后低钙血症率或喉返神经麻痹率均无差异。
关键数值与推荐
- 活性止血剂对比对照组和被动止血剂组,总术后失血量显著更低且手术时间缩短。
临床怎么用
- 不应仅以预防临床相关出血为目的常规使用局部止血剂。
- 活性止血剂或有助于减少总失血量和缩短手术时间,但需结合个体情况权衡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective of this study was to investigate the potential benefit of local haemostatic agents for the prevention of postoperative bleeding after thyroidectomy. METHODS: A systematic literature search was performed, and RCTs involving adult patients who underwent thyroid surgery using either active (AHA) or passive (PHA) haemostatic agents were included in the review. The main outcome was the rate of cervical haematoma that required reoperation. A Bayesian random-effects model was used for network meta-analysis with minimally informative prior distributions. RESULTS: Thirteen RCTs were included. The rate of cervical haematoma requiring reoperation ranged from 0 to 9·1 per cent, and was not reduced by haemostatic agents: AHA versus control (odds ratio (OR) 1·53, 95 per cent credibility interval 0·21 to 10·77); PHA versus control (OR 2·74, 0·41 to 16·62) and AHA versus PHA (OR 1·77, 0·12 to 25·06). No difference was observed in the time required for drain removal, duration of hospital stay, and the rate of postoperative hypocalcaemia or recurrent nerve palsy. AHA led to a significantly lower total postoperative blood loss and reduced operating time in comparison with both the control and PHA groups. CONCLUSION: The general use of local haemostatic agents has not been shown to reduce the rate of clinically relevant bleeding.
引用
- Polychronidis G, Hüttner FJ, Contin P, et al. Network meta-analysis of topical haemostatic agents in thyroid surgery. Br J Surg. 2018. PMID: 30199093. doi:10.1002/bjs.10975
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。